Literature DB >> 16186632

Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease?

Agnes L Nishimura1, Camila Guindalini, João R M Oliveira, Ricardo Nitrini, Valéria S Bahia, Paulo R de Brito-Marques, Paulo A Otto, Mayana Zatz.   

Abstract

Different studies have attempted to find polymorphisms involved in the serotonergic pathway that could be involved in mood disorders and late-onset Alzheimer's disease (LOAD) symptoms. Here, we compared the frequency of two polymorphisms: monoamine oxidase A (MAOA) and serotonin transporter in LOAD patients versus controls. No evidence of association was observed when these polymorphisms were compared separately; however, the combination of the MAOA allele 1+the short allele of 5-HTTLPR+ApoE-epsilon4 was significantly more frequent in patients than in controls. It reinforces the hypothesis that different genes acting together might play a role in AD susceptibility. Based on these data, we suggest replicating these studies in larger samples of LOAD patients belonging to different ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186632     DOI: 10.1385/JMN:27:2:213

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Association study for a functional serotonin transporter gene polymorphism and late-onset Alzheimer's disease for Chinese patients.

Authors:  S J Tsai; C J Hong; T Y Liu; C Y Cheng; H C Liu
Journal:  Neuropsychobiology       Date:  2001       Impact factor: 2.328

4.  Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.

Authors:  M Weinstock; N Kirschbaum-Slager; P Lazarovici; C Bejar; M B Youdim; S Shoham
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

5.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.

Authors:  D A Collier; G Stöber; T Li; A Heils; M Catalano; D Di Bella; M J Arranz; R M Murray; H P Vallada; D Bengel; C R Müller; G W Roberts; E Smeraldi; G Kirov; P Sham; K P Lesch
Journal:  Mol Psychiatry       Date:  1996-12       Impact factor: 15.992

6.  Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association.

Authors:  H Kunugi; A Ueki; M Otsuka; K Isse; H Hirasawa; N Kato; T Nabika; S Kobayashi; S Nanko
Journal:  Am J Med Genet       Date:  2000-06-12

7.  Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter.

Authors:  R A Furlong; L Ho; J S Rubinsztein; C Walsh; E S Paykel; D C Rubinsztein
Journal:  Am J Med Genet       Date:  1999-08-20

8.  A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders.

Authors:  H Kunugi; S Ishida; T Kato; M Tatsumi; T Sakai; M Hattori; T Hirose; S Nanko
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

Review 9.  Dietary factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Lancet Neurol       Date:  2004-10       Impact factor: 44.182

10.  The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease.

Authors:  J R Oliveira; R M Gallindo; L G Maia; P R Brito-Marques; P A Otto; M R Passos-Bueno; M A Morais; M Zatz
Journal:  Mol Psychiatry       Date:  1998-09       Impact factor: 15.992

View more
  8 in total

1.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

2.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

Review 3.  Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.

Authors:  Makoto Naoi; Peter Riederer; Wakako Maruyama
Journal:  J Neural Transm (Vienna)       Date:  2015-01-22       Impact factor: 3.575

4.  The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population.

Authors:  J R M Oliveira; A L Nishimura; R R Lemos; M Zatz
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

5.  Protective effect of the APOE-e3 allele in Alzheimer's disease.

Authors:  B V P de-Almada; L D de-Almeida; D Camporez; M V D de-Moraes; R L Morelato; A M S Perrone; L Belcavello; I D Louro; F de-Paula
Journal:  Braz J Med Biol Res       Date:  2011-11-08       Impact factor: 2.590

6.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

7.  Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex.

Authors:  Maa O Quartey; Jennifer N K Nyarko; Paul R Pennington; Ryan M Heistad; Paula C Klassen; Glen B Baker; Darrell D Mousseau
Journal:  Front Neurosci       Date:  2018-06-26       Impact factor: 4.677

8.  Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples.

Authors:  Jennifer N K Nyarko; Maa O Quartey; Ryan M Heistad; Paul R Pennington; Lisa J Poon; Kaeli J Knudsen; Odette Allonby; Amr M El Zawily; Andrew Freywald; Gail Rauw; Glen B Baker; Darrell D Mousseau
Journal:  Front Neurosci       Date:  2018-08-10       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.